Esophageal Carcinoma — Trials

Esophageal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

807 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 307
Recruiting: 179
Ph III recruiting: 26
Growth YoY: +33.8%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 26.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (62)

clinicaltrialsPublishedShowing 201–208 of 208 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04973306	Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC(iCROSS)	recruiting	Phase 2 / Phase 3	176	Shanghai Zhongshan HospitalOTHER	1	Jun 30, 2022	clinicaltrials
NCT05188313	TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer(TRAP-2)	recruiting	Phase 3	376	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER